We first set out to measure gene expression of CLEC16A and the surrounding genes, CIITA, DEXI and SOCS1, in peripheral T cells purified from treatment-naïve, female RRMS patients and age- and sex-matched healthy controls (Table 1). Here, CLEC16A is linked to relapsing-remitting multiple sclerosis.